150 related articles for article (PubMed ID: 35960412)
1. Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study.
Guizani I; Zidi W; Zayani Y; Nesrine F; Douik H; Sanhaji H; Mourali MS; Feki M; Allal-Elasmi M
Mol Biol Rep; 2022 Oct; 49(10):9171-9179. PubMed ID: 35960412
[TBL] [Abstract][Full Text] [Related]
2. Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.
Xu X; Wang L; Xu C; Zhang P; Yong F; Liu H; Wang J; Shi Y
Coron Artery Dis; 2013 Jun; 24(4):259-65. PubMed ID: 23377317
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
Lamblin N; Bauters C; Hermant X; Lablanche JM; Helbecque N; Amouyel P
J Am Coll Cardiol; 2002 Jul; 40(1):43-8. PubMed ID: 12103254
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Pleskovič A; Letonja MŠ; Vujkovac AC; Starčević JN; Caprnda M; Curilla E; Mozos I; Kruzliak P; Prosecky R; Petrovič D
Vasa; 2017 Aug; 46(5):363-369. PubMed ID: 28521653
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: a 5 years cohort study.
Guizani I; Zidi W; Zayani Y; Boudiche S; Hadj-Taieb S; Sanhaji H; Zaroui A; Mechmeche R; Mourali MS; Feki M; Allal-Elasmi M
Mol Biol Rep; 2019 Oct; 46(5):4699-4707. PubMed ID: 31218540
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.
Park JA; Shin KS; Kim YW
J Korean Med Sci; 2005 Aug; 20(4):607-11. PubMed ID: 16100452
[TBL] [Abstract][Full Text] [Related]
8. [Association between single nucleotide polymorphisms of matrix metalloproteinase-3 gene and the severity of coronary atherosclerosis in patients with coronary artery disease].
Wu NQ; Song L; Hua YH; Lu XF; Ye J; Li JX; Gu DF; Yang YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):501-5. PubMed ID: 19100060
[TBL] [Abstract][Full Text] [Related]
9. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.
Lin CC; Yang WC; Chung MY; Lee PC
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1805-14. PubMed ID: 20616161
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease.
Jguirim-Souissi I; Jelassi A; Slimani A; Addad F; Hassine M; Hamda KB; Najah M; Maatouk F; Rouis M; Slimane MN
Coron Artery Dis; 2011; 22(6):388-93. PubMed ID: 21606841
[TBL] [Abstract][Full Text] [Related]
12. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
Samnegård A; Silveira A; Lundman P; Boquist S; Odeberg J; Hulthe J; McPheat W; Tornvall P; Bergstrand L; Ericsson CG; Hamsten A; Eriksson P
J Intern Med; 2005 Nov; 258(5):411-9. PubMed ID: 16238676
[TBL] [Abstract][Full Text] [Related]
13. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.
Elahirad S; Elieh Ali Komi D; Kiani A; Mohammadi-Noori E; Vaisi-Raygani A; Mozafari H; Bahrehmand F; Saidi M; Toupchi-Khosroshahi V; Salehi N
Cardiovasc Toxicol; 2022 Feb; 22(2):118-129. PubMed ID: 34731407
[TBL] [Abstract][Full Text] [Related]
14. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
[TBL] [Abstract][Full Text] [Related]
15. The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients.
Opstad TB; Pettersen AÅ; Arnesen H; Seljeflot I
PLoS One; 2013; 8(9):e74498. PubMed ID: 24040261
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.
Ghilardi G; Biondi ML; DeMonti M; Turri O; Guagnellini E; Scorza R
Stroke; 2002 Oct; 33(10):2408-12. PubMed ID: 12364729
[TBL] [Abstract][Full Text] [Related]
17. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL
Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
[TBL] [Abstract][Full Text] [Related]
18. Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.
Liutkevicius V; Lesauskaite V; Liutkeviciene R; Vaiciulis P; Uloza V
In Vivo; 2020; 34(1):267-274. PubMed ID: 31882488
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
